Biogened S.A. (WSE:BGD)
Poland · Delayed Price · Currency is PLN 19.00
0.00 (0.00%)
Last updated: Nov 3, 2026, 1:05 PM CET
Biogened Revenue
Biogened had revenue of 30.81M PLN in the quarter ending June 30, 2026, with 5.29% growth. This brings the company's total for the last twelve months to 111.04M, down -1.52% year-over-year. In the year 2025, Biogened had annual revenue of 114.04M with 2.81% growth. That makes Biogened the 31,809th largest company in the world by revenue and 256th in Poland.
Revenue (ttm)
111.04M
Revenue Growth
-1.52%
P/S Ratio
0.42
Revenue / Employee
591.98K
Employees
186
Market Cap
46.67M
Revenue by Geography
- Export 5.74B 50.8%
- Poland 5.57B 49.2%
Fiscal year ended Dec 31, 2025 See the full Biogened breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 114.04M | 3.11M | 2.81% |
| Dec 31, 2024 | 110.93M | 15.37M | 16.09% |
| Dec 31, 2023 | 95.56M | 15.94M | 20.02% |
| Dec 31, 2022 | 79.62M | 14.30M | 21.89% |
| Dec 31, 2021 | 65.32M | 16.99M | 35.15% |
| Dec 31, 2020 | 48.33M | 1.70M | 3.64% |
| Dec 31, 2019 | 46.63M | 6.39M | 15.88% |
| Dec 31, 2018 | 40.24M | 6.67M | 19.86% |
| Dec 31, 2017 | 33.57M | 4.96M | 17.33% |
| Dec 31, 2016 | 28.61M | -1.24M | -4.16% |
| Dec 31, 2015 | 29.86M | 7.21M | 31.84% |
| Dec 31, 2014 | 22.65M | 224.75K | 1.00% |
| Dec 31, 2013 | 22.42M | -3.29M | -12.79% |
| Dec 31, 2012 | 25.71M | 914.81K | 3.69% |
| Dec 31, 2011 | 24.79M | 3.52M | 16.56% |
| Dec 31, 2010 | 21.27M | -3.97M | -15.74% |
| Dec 31, 2009 | 25.25M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 14.14B |
| Diagnostyka | 2.58B |
| Synektik Spólka Akcyjna | 932.97M |
| Voxel | 640.61M |
| BioMaxima | 60.64M |
| Genomed Spólka Akcyjna | 30.64M |
| Read-Gene | 16.66M |
| MedApp | 6.75M |